Market Place
Sourcing Support
Fennec Pharmaceuticals Announces NICE Recommendation for Pedmarqsi®
20 Dec 2024 //
GLOBENEWSWIRE
Fennec Pharma To Join Upcoming Investor Conference
12 Dec 2024 //
GLOBENEWSWIRE
Fennec Pharma to Participate in Upcoming Investor Conference
13 Nov 2024 //
GLOBENEWSWIRE
Fennec Pharma Reports Q3 2024 Financial Results & Business Update
07 Nov 2024 //
GLOBENEWSWIRE
Fennec Pharmaceuticals to Report Q3 2024 Results on Nov 7
31 Oct 2024 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Boosts Leadership with Key Appointments
28 Oct 2024 //
GLOBENEWSWIRE
Fennec Pharmaceuticals To Participate In Investor Conferences
05 Sep 2024 //
GLOBENEWSWIRE
Fennec Pharma Reports Q2 2024 Results And Business Update
13 Aug 2024 //
GLOBENEWSWIRE
Fennec Pharma To Report Q2 2024 Results On August 13
06 Aug 2024 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Appoints Jeffrey Hackman As CEO And Director
05 Aug 2024 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Announces Management Change
01 Jul 2024 //
GLOBENEWSWIRE
Fennec Announces Results of Annual Meeting
25 Jun 2024 //
GLOBENEWSWIRE
Fennec Pharma Reports Q1 2024 Results, Business Update
14 May 2024 //
GLOBENEWSWIRE
Fennec Pharma to Report Q1 2024 Results on May 14
06 May 2024 //
GLOBENEWSWIRE
Fennec Reports Full Year and Fourth Quarter 2023 Financial Results
21 Mar 2024 //
GLOBENEWSWIRE
Fennec to Report Full Year & Fourth Quarter 2023 FYR
19 Mar 2024 //
GLOBENEWSWIRE
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement
18 Mar 2024 //
PR NEWSWIRE
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement
17 Mar 2024 //
GLOBENEWSWIRE
Fennec Reports Net Revenue for Fourth Quarter and Full-Year 2023 Results
29 Feb 2024 //
GLOBENEWSWIRE
FDA Issues Reminder of Non-Substitution of PEDMARK for Pediatric Patients
01 Feb 2024 //
GLOBENEWSWIRE
Fennec Announces Incremental $5 Million Investment from Petrichor
05 Dec 2023 //
GLOBENEWSWIRE
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
09 Nov 2023 //
GLOBENEWSWIRE
Fennec Announces Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
Fennec to Report Third Quarter 2023 Financial Results on November 6, 2023
30 Oct 2023 //
GLOBENEWSWIRE
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
07 Sep 2023 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
Fennec to Report Second Quarter 2023 Financial Results on August 3, 2023
31 Jul 2023 //
GLOBENEWSWIRE
Fennec Announces Results of Annual Meeting
12 Jun 2023 //
GLOBENEWSWIRE
Fennec Announces European Commission Marketing Authorization for Pedmarqsi
07 Jun 2023 //
BIOSPACE
Fennec Announces European Commission Marketing Authorization for Pedmarqsi
06 Jun 2023 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Fennec Pharmaceuticals to Report 1Q 2023 FYR on May 11, 2023
08 May 2023 //
GLOBENEWSWIRE
Fennec Pharma Receives Positive CHMP Opinion for (sodium thiosulfate)
31 Mar 2023 //
GLOBENEWSWIRE
Fennec Reports Full Year and 4Q Financial Results 2022Financial Results
30 Mar 2023 //
GLOBENEWSWIRE
FDA Grants Orphan Drug to Pedmark Injection for Prevention of Ototoxicity
01 Feb 2023 //
ONCLIVE
Fennec Pharma Announces PEDMARK Receives Orphan Drug Exclusivity from FDA
31 Jan 2023 //
GLOBENEWSWIRE
Fennec Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK
25 Jan 2023 //
GLOBENEWSWIRE
Fennec Announces Third Quarter 2022 Financial Results and Provides
11 Nov 2022 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK®
17 Oct 2022 //
GLOBENEWSWIRE
U.S. FDA approves Fennec`s hearing loss therapy
22 Sep 2022 //
REUTERS
Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor
22 Aug 2022 //
GLOBENEWSWIRE
Fennec Pharma Announces Second Quarter 2022 Financial Results
12 Aug 2022 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
01 Aug 2022 //
GLOBENEWSWIRE
Fennec Announces Results of Annual Meeting
14 Jun 2022 //
GLOBENEWSWIRE
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
23 May 2022 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Fennec looks for FDA approval for hearing loss drug haunted by problems
28 Apr 2022 //
ENDPTS
Fennec Pharma Resubmits NDA to U.S. FDA for Pedmark
24 Mar 2022 //
GLOBENEWSWIRE
Fennec Pharma Announces Fiscal Year 2021 Financial Results
28 Feb 2022 //
GLOBENEWSWIRE
Fennec Pharmaceuticals Announces Management Change
31 Jan 2022 //
GLOBENEWSWIRE
Fennec preps for second CRL for potential hearing loss drug
30 Nov 2021 //
ENDPTS
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA
29 Nov 2021 //
GLOBENEWSWIRE
Fennec Shares Plunge as Pedmark Appears Headed for FDA Rejection >FENC
29 Nov 2021 //
MARKETWATCH
Fennec Announces Results of Annual Meeting
29 Jun 2021 //
GLOBENEWSWIRE
Fennec Pharma Announces Amendment to Increase Existing Senior Debt Facility
24 Jun 2021 //
GLOBENEWSWIRE
Fennec Announces FDA Acceptance of New Drug Application Resubmission for PEDMARK
22 Jun 2021 //
GLOBENEWSWIRE
Fennec Announces Issuance of U.S. Patent for PEDMARK™
21 Sep 2020 //
GLOBENEWSWIRE
Fennec Receives Complete Response Letter from the FDA for its NDA for PEDMARK™
11 Aug 2020 //
GLOBENEWSWIRE
